32 phenotypes from 4 alleles in 4 genetic backgrounds

Allelic Composition Genetic Background	Annotated Term	Reference
Pttg1tm1.2Kna/Pttg1tm1.2Kna involves: 129P2/OlaHsd * C57BL/6	reduced fertility	J:107916
Pttg1tm1b(EUCOMM)Wtsi/Pttg1tm1b(EUCOMM)Wtsi C57BL/6N-Pttg1tm1b(EUCOMM)Wtsi/Tcp	abnormal seminal vesicle morphology	J:211773
	increased circulating triglyceride level	J:211773
	increased grip strength	J:211773
	preweaning lethality, incomplete penetrance	J:211773
	small kidney	J:211773
	small spleen	J:211773
	small testis	J:211773
Pttg1tm1Pzg/Pttg1tm1Pzg involves: 129S7/SvEvBrd * C57BL/6	abnormal cell cycle checkpoint function	J:121688
	decreased cell proliferation	J:121688
	normal mortality/aging	J:121688
Pttg1tm1Sme/Pttg1tm1Sme involves: 129S4/SvJae * C57BL/6	abnormal epididymal fat pad morphology	J:82724
	abnormal immune system organ morphology	J:72267
	abnormal pancreatic beta cell morphology	J:82724
	decreased body weight	J:82724
	decreased circulating insulin level	J:82724
	decreased IgG level	J:72267
	decreased IgM level	J:72267
	decreased immunoglobulin level	J:72267
	decreased litter size	J:72267
	decreased pancreatic beta cell mass	J:82724
	decreased pancreatic beta cell proliferation	J:82724
	decreased spleen weight	J:72267
	decreased testis weight	J:72267
	hyperglycemia	J:82724
	increased bleeding time	J:72267
	increased food intake	J:82724
	increased T cell number	J:72267
	polyuria	J:82724
	reduced female fertility	J:72267
	thrombocytopenia	J:72267
	thymus hyperplasia	J:72267